Fungal metabolites as pharmaceuticals

Andrew M. Beekman; Russell A. Barrow

doi:10.1071/CH13639

Fungal metabolites as pharmaceuticals

Andrew M. Beekman, Russell A. Barrow^*

^*Corresponding author for this work

Research output: Contribution to journal › Review article › peer-review

50 Citations (Scopus)

Abstract

Natural products, their derivatives or compounds based on natural product leads constitute ∼50% of clinically used pharmaceuticals. This review highlights pharmaceuticals currently used in Australia and New Zealand that have their origins in fungal metabolites, discussing the natural products chemistry and medicinal chemistry leading to their application as pharmaceuticals.

Original language	English
Pages (from-to)	827-843
Number of pages	17
Journal	Australian Journal of Chemistry
Volume	67
Issue number	6
DOIs	https://doi.org/10.1071/CH13639
Publication status	Published - 2014

Access to Document

10.1071/CH13639

Cite this

@article{1375c4f11ba14b59ac2852fdd36a61b4,

title = "Fungal metabolites as pharmaceuticals",

abstract = "Natural products, their derivatives or compounds based on natural product leads constitute ∼50% of clinically used pharmaceuticals. This review highlights pharmaceuticals currently used in Australia and New Zealand that have their origins in fungal metabolites, discussing the natural products chemistry and medicinal chemistry leading to their application as pharmaceuticals.",

author = "Beekman, {Andrew M.} and Barrow, {Russell A.}",

year = "2014",

doi = "10.1071/CH13639",

language = "English",

volume = "67",

pages = "827--843",

journal = "Australian Journal of Chemistry",

issn = "0004-9425",

publisher = "CSIRO",

number = "6",

}

TY - JOUR

T1 - Fungal metabolites as pharmaceuticals

AU - Beekman, Andrew M.

AU - Barrow, Russell A.

PY - 2014

Y1 - 2014

N2 - Natural products, their derivatives or compounds based on natural product leads constitute ∼50% of clinically used pharmaceuticals. This review highlights pharmaceuticals currently used in Australia and New Zealand that have their origins in fungal metabolites, discussing the natural products chemistry and medicinal chemistry leading to their application as pharmaceuticals.

AB - Natural products, their derivatives or compounds based on natural product leads constitute ∼50% of clinically used pharmaceuticals. This review highlights pharmaceuticals currently used in Australia and New Zealand that have their origins in fungal metabolites, discussing the natural products chemistry and medicinal chemistry leading to their application as pharmaceuticals.

UR - http://www.scopus.com/inward/record.url?scp=84902477270&partnerID=8YFLogxK

U2 - 10.1071/CH13639

DO - 10.1071/CH13639

M3 - Review article

SN - 0004-9425

VL - 67

SP - 827

EP - 843

JO - Australian Journal of Chemistry

JF - Australian Journal of Chemistry

IS - 6

ER -

Fungal metabolites as pharmaceuticals

Abstract

Access to Document

Other files and links

Fingerprint

Cite this